DYRK1B and rhabdomyosarcoma: Because DYRK1B (i) is important for rhabdomyosarcoma growth [41], (ii) can block HH signaling [40], and (iii) is a novel ERK2 substrate [42], it is possible that ERK represses the HH pathway via DYRK1B.